Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ppara
|
ENSMUSG00000022383.7 | peroxisome proliferator activated receptor alpha |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_85771762_85772137 | Ppara | 265 | 0.892657 | -0.75 | 4.4e-11 | Click! |
chr15_85772274_85772444 | Ppara | 145 | 0.945958 | -0.73 | 2.5e-10 | Click! |
chr15_85771411_85771582 | Ppara | 718 | 0.611629 | -0.68 | 1.4e-08 | Click! |
chr15_85777349_85777500 | Ppara | 5210 | 0.160378 | -0.64 | 1.2e-07 | Click! |
chr15_85774379_85774742 | Ppara | 2346 | 0.232253 | -0.63 | 2.6e-07 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_127698278_127698609 | 71.34 |
Gm16238 |
predicted gene 16238 |
5923 |
0.12 |
chr2_34486214_34486378 | 40.60 |
Mapkap1 |
mitogen-activated protein kinase associated protein 1 |
41949 |
0.13 |
chr12_3236518_3237725 | 31.98 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr4_110050502_110051534 | 31.82 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr10_128381022_128381494 | 31.36 |
Mir6914 |
microRNA 6914 |
1580 |
0.13 |
chr4_156343099_156343378 | 27.05 |
Vmn2r125 |
vomeronasal 2, receptor 125 |
962 |
0.53 |
chr19_61225302_61226760 | 26.51 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr4_156341977_156342304 | 25.66 |
Vmn2r125 |
vomeronasal 2, receptor 125 |
2060 |
0.28 |
chr8_125401477_125401784 | 25.46 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
91080 |
0.09 |
chr9_124441790_124442379 | 22.76 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
662 |
0.65 |
chr2_26594675_26595827 | 21.86 |
Egfl7 |
EGF-like domain 7 |
3104 |
0.11 |
chr10_62338357_62339018 | 21.00 |
Hk1os |
hexokinase 1, opposite strand |
1569 |
0.3 |
chr4_156342718_156343009 | 20.82 |
Vmn2r125 |
vomeronasal 2, receptor 125 |
1337 |
0.4 |
chr1_190956801_190956952 | 19.59 |
Angel2 |
angel homolog 2 |
19624 |
0.11 |
chr6_125163930_125164575 | 18.24 |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
664 |
0.41 |
chr5_140044616_140045012 | 17.87 |
Gm43702 |
predicted gene 43702 |
12638 |
0.16 |
chr11_43548063_43548966 | 17.82 |
Ccnjl |
cyclin J-like |
19268 |
0.13 |
chr8_122695553_122695753 | 15.62 |
Gm10612 |
predicted gene 10612 |
2207 |
0.17 |
chr7_31127074_31128340 | 15.23 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr2_30718241_30719386 | 14.87 |
Gm14488 |
predicted gene 14488 |
1244 |
0.36 |
chr17_13590938_13591623 | 13.99 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
22416 |
0.14 |
chr8_47284778_47285157 | 13.82 |
Stox2 |
storkhead box 2 |
4395 |
0.28 |
chr11_120349471_120350657 | 13.76 |
0610009L18Rik |
RIKEN cDNA 0610009L18 gene |
1386 |
0.18 |
chr10_81328001_81328827 | 13.05 |
Tbxa2r |
thromboxane A2 receptor |
317 |
0.68 |
chr19_3912286_3912658 | 12.93 |
Ndufs8 |
NADH:ubiquinone oxidoreductase core subunit S8 |
16 |
0.94 |
chr7_49298503_49298820 | 12.85 |
Nav2 |
neuron navigator 2 |
5477 |
0.26 |
chr1_164460892_164461591 | 12.85 |
Gm32391 |
predicted gene, 32391 |
1201 |
0.38 |
chr10_42477881_42479089 | 12.50 |
Afg1l |
AFG1 like ATPase |
70 |
0.97 |
chr2_107125684_107125835 | 12.32 |
Gm13903 |
predicted gene 13903 |
1799 |
0.38 |
chr7_130977605_130978173 | 12.24 |
Htra1 |
HtrA serine peptidase 1 |
3781 |
0.24 |
chr7_137316861_137317678 | 12.04 |
Ebf3 |
early B cell factor 3 |
2824 |
0.26 |
chr13_23226264_23226415 | 11.92 |
Vmn1r-ps133 |
vomeronasal 1 receptor, pseudogene 133 |
2413 |
0.12 |
chr17_7538090_7538689 | 11.53 |
Gm33086 |
predicted gene, 33086 |
37801 |
0.17 |
chr8_36457363_36458468 | 11.30 |
Trmt9b |
tRNA methyltransferase 9B |
267 |
0.92 |
chr7_49145487_49145638 | 11.18 |
9130015G15Rik |
RIKEN cDNA 9130015G15 gene |
11286 |
0.2 |
chr19_24571856_24572039 | 11.18 |
Gm50341 |
predicted gene, 50341 |
15595 |
0.19 |
chr18_77773888_77774616 | 11.09 |
Atp5a1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1 |
260 |
0.59 |
chr7_19075475_19075761 | 11.05 |
Dmwd |
dystrophia myotonica-containing WD repeat motif |
609 |
0.48 |
chr12_3364588_3366025 | 11.03 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr8_86438967_86439169 | 10.82 |
Abcc12 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 12 |
95679 |
0.07 |
chr1_155233440_155234889 | 10.79 |
BC034090 |
cDNA sequence BC034090 |
1253 |
0.38 |
chr7_34570196_34571084 | 10.74 |
Gm12784 |
predicted gene 12784 |
23434 |
0.15 |
chr14_14349938_14350878 | 10.63 |
Il3ra |
interleukin 3 receptor, alpha chain |
787 |
0.48 |
chr10_79681206_79682337 | 10.33 |
Cdc34 |
cell division cycle 34 |
424 |
0.63 |
chr1_81520769_81521201 | 10.32 |
Gm37210 |
predicted gene, 37210 |
1356 |
0.55 |
chr5_34182958_34183168 | 10.19 |
Mxd4 |
Max dimerization protein 4 |
1307 |
0.27 |
chr17_56472537_56473329 | 10.16 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1694 |
0.3 |
chr2_32628138_32628539 | 10.05 |
Ak1 |
adenylate kinase 1 |
52 |
0.93 |
chr7_67462561_67462982 | 10.05 |
Gm33926 |
predicted gene, 33926 |
18838 |
0.19 |
chr10_25459089_25459284 | 10.00 |
Epb41l2 |
erythrocyte membrane protein band 4.1 like 2 |
7787 |
0.21 |
chr1_85588537_85589247 | 9.96 |
Sp110 |
Sp110 nuclear body protein |
299 |
0.81 |
chr8_94154535_94154978 | 9.91 |
Mt3 |
metallothionein 3 |
2010 |
0.19 |
chr1_42703489_42704501 | 9.91 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4057 |
0.16 |
chr7_112222783_112223211 | 9.87 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
2859 |
0.36 |
chr19_10041145_10042475 | 9.81 |
Fads3 |
fatty acid desaturase 3 |
78 |
0.96 |
chr9_124439906_124440949 | 9.72 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr16_63747767_63748162 | 9.70 |
Gm22769 |
predicted gene, 22769 |
430 |
0.91 |
chr10_62865964_62866638 | 9.68 |
Tet1 |
tet methylcytosine dioxygenase 1 |
997 |
0.41 |
chr16_17987771_17988057 | 9.65 |
Vpreb2 |
pre-B lymphocyte gene 2 |
7486 |
0.13 |
chr8_55121794_55122373 | 9.51 |
Gm8734 |
predicted gene 8734 |
40368 |
0.14 |
chr3_62458622_62458788 | 9.48 |
Dhx36 |
DEAH (Asp-Glu-Ala-His) box polypeptide 36 |
13882 |
0.24 |
chr11_113788543_113789130 | 9.36 |
Sdk2 |
sidekick cell adhesion molecule 2 |
21587 |
0.15 |
chr14_14350947_14351733 | 9.28 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr11_22858998_22860305 | 9.24 |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
106 |
0.89 |
chr13_99514035_99514335 | 9.21 |
Map1b |
microtubule-associated protein 1B |
2333 |
0.23 |
chr10_62287570_62287721 | 9.16 |
Hk1 |
hexokinase 1 |
2684 |
0.24 |
chr2_93199380_93200028 | 9.10 |
Trp53i11 |
transformation related protein 53 inducible protein 11 |
785 |
0.69 |
chr4_141312456_141313176 | 9.07 |
Epha2 |
Eph receptor A2 |
3922 |
0.13 |
chr3_79628270_79629417 | 8.98 |
Etfdh |
electron transferring flavoprotein, dehydrogenase |
20 |
0.75 |
chr4_105364618_105364769 | 8.90 |
Gm12722 |
predicted gene 12722 |
10253 |
0.3 |
chr9_49980492_49980798 | 8.88 |
Gm47543 |
predicted gene, 47543 |
25767 |
0.24 |
chr7_79148252_79148910 | 8.86 |
Mfge8 |
milk fat globule-EGF factor 8 protein |
350 |
0.87 |
chr1_144098935_144099146 | 8.74 |
Rgs13 |
regulator of G-protein signaling 13 |
78235 |
0.1 |
chr16_3843890_3844041 | 8.63 |
Zfp174 |
zinc finger protein 174 |
3303 |
0.12 |
chr18_56287782_56287935 | 8.59 |
Gm50385 |
predicted gene, 50385 |
3006 |
0.31 |
chr8_124106467_124106789 | 8.59 |
Gm3889 |
predicted gene 3889 |
53445 |
0.08 |
chrX_7287132_7287401 | 8.54 |
Clcn5 |
chloride channel, voltage-sensitive 5 |
31904 |
0.09 |
chr2_153425549_153426538 | 8.54 |
Gm14472 |
predicted gene 14472 |
12194 |
0.16 |
chr6_145457135_145457443 | 8.54 |
Lmntd1 |
lamin tail domain containing 1 |
6522 |
0.16 |
chr9_41375999_41376652 | 8.49 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
4 |
0.98 |
chr5_116019192_116019710 | 8.49 |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
1240 |
0.35 |
chr2_125617408_125617804 | 8.46 |
Cep152 |
centrosomal protein 152 |
7507 |
0.23 |
chr1_184503919_184504070 | 8.39 |
1700112H15Rik |
RIKEN cDNA 1700112H15 gene |
53697 |
0.11 |
chr1_184810736_184811383 | 8.38 |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
138 |
0.95 |
chr8_55358672_55359287 | 8.35 |
Gm20586 |
predicted gene, 20586 |
173312 |
0.03 |
chr8_47346144_47346353 | 8.29 |
Stox2 |
storkhead box 2 |
6100 |
0.26 |
chr8_104590953_104591575 | 8.29 |
Pdp2 |
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
187 |
0.89 |
chr13_12293863_12294038 | 8.28 |
Actn2 |
actinin alpha 2 |
11403 |
0.16 |
chr3_153943944_153945147 | 8.27 |
Acadm |
acyl-Coenzyme A dehydrogenase, medium chain |
78 |
0.95 |
chr8_102596538_102596950 | 8.17 |
Cdh11 |
cadherin 11 |
40575 |
0.15 |
chr1_85279771_85280739 | 8.13 |
Gm16026 |
predicted pseudogene 16026 |
5148 |
0.14 |
chr12_77501913_77502212 | 8.10 |
Gm48177 |
predicted gene, 48177 |
24336 |
0.17 |
chr9_44721587_44722104 | 8.07 |
Phldb1 |
pleckstrin homology like domain, family B, member 1 |
421 |
0.66 |
chr13_38148355_38148667 | 8.07 |
Dsp |
desmoplakin |
2783 |
0.22 |
chr7_12979544_12979864 | 8.02 |
Zfp446 |
zinc finger protein 446 |
184 |
0.86 |
chr8_55352073_55352667 | 8.00 |
Gm20586 |
predicted gene, 20586 |
179921 |
0.03 |
chr7_89632412_89633229 | 7.92 |
Me3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
66 |
0.79 |
chr17_9726102_9726458 | 7.89 |
Gm34684 |
predicted gene, 34684 |
73 |
0.98 |
chr10_81059624_81060601 | 7.88 |
Sgta |
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
3 |
0.94 |
chr1_51992333_51992484 | 7.86 |
Stat4 |
signal transducer and activator of transcription 4 |
5260 |
0.18 |
chr1_85089758_85090158 | 7.83 |
Gm10553 |
predicted gene 10553 |
9554 |
0.09 |
chr5_120490584_120491079 | 7.76 |
Gm15690 |
predicted gene 15690 |
9928 |
0.1 |
chr10_78464271_78465733 | 7.74 |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
27 |
0.93 |
chr11_8523634_8524133 | 7.71 |
Tns3 |
tensin 3 |
21468 |
0.27 |
chr10_31173126_31173598 | 7.71 |
Gm23790 |
predicted gene, 23790 |
9730 |
0.2 |
chr11_74649608_74650568 | 7.71 |
Cluh |
clustered mitochondria (cluA/CLU1) homolog |
258 |
0.9 |
chr2_174294955_174296140 | 7.71 |
Gnasas1 |
GNAS antisense RNA 1 |
111 |
0.94 |
chr10_99461229_99461418 | 7.66 |
Gm35035 |
predicted gene, 35035 |
1093 |
0.37 |
chr11_20859449_20859833 | 7.65 |
Gm22807 |
predicted gene, 22807 |
11760 |
0.15 |
chr6_89008167_89008318 | 7.62 |
4933427D06Rik |
RIKEN cDNA 4933427D06 gene |
57559 |
0.1 |
chr17_47975997_47976716 | 7.60 |
Gm14871 |
predicted gene 14871 |
27216 |
0.11 |
chr10_122859109_122859260 | 7.58 |
Ppm1h |
protein phosphatase 1H (PP2C domain containing) |
36184 |
0.15 |
chr1_13329752_13329931 | 7.58 |
Gm23169 |
predicted gene, 23169 |
4768 |
0.13 |
chr15_76343393_76344278 | 7.55 |
Cyc1 |
cytochrome c-1 |
10 |
0.92 |
chr5_112521223_112521397 | 7.55 |
Sez6l |
seizure related 6 homolog like |
46183 |
0.1 |
chr8_55355373_55355937 | 7.53 |
Gm20586 |
predicted gene, 20586 |
176636 |
0.03 |
chr8_84990346_84991110 | 7.53 |
Hook2 |
hook microtubule tethering protein 2 |
86 |
0.9 |
chr5_33995599_33996957 | 7.52 |
Nat8l |
N-acetyltransferase 8-like |
294 |
0.82 |
chr13_90394800_90394980 | 7.52 |
Gm37708 |
predicted gene, 37708 |
8333 |
0.24 |
chr11_109927007_109927334 | 7.48 |
Gm11697 |
predicted gene 11697 |
9146 |
0.22 |
chr10_81364518_81366962 | 7.46 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr2_121294292_121294548 | 7.43 |
Map1a |
microtubule-associated protein 1 A |
1034 |
0.35 |
chr13_44085654_44085928 | 7.42 |
Gm33630 |
predicted gene, 33630 |
14169 |
0.18 |
chr17_67629247_67629466 | 7.41 |
Gm36201 |
predicted gene, 36201 |
24 |
0.98 |
chr15_85679706_85679881 | 7.40 |
Lncppara |
long noncoding RNA near Ppara |
23980 |
0.12 |
chr10_21046286_21046437 | 7.37 |
Gm20149 |
predicted gene, 20149 |
2538 |
0.23 |
chr11_118247752_118249318 | 7.35 |
Cyth1 |
cytohesin 1 |
25 |
0.97 |
chr14_101859629_101859828 | 7.35 |
Lmo7 |
LIM domain only 7 |
9742 |
0.27 |
chr5_33234788_33235010 | 7.32 |
Ctbp1 |
C-terminal binding protein 1 |
14351 |
0.14 |
chr7_117686198_117686394 | 7.27 |
Gm24063 |
predicted gene, 24063 |
90498 |
0.1 |
chr8_55115169_55115732 | 7.25 |
Gm8734 |
predicted gene 8734 |
33735 |
0.14 |
chr10_60277532_60278257 | 7.24 |
Psap |
prosaposin |
266 |
0.92 |
chr16_31066371_31066571 | 7.22 |
Xxylt1 |
xyloside xylosyltransferase 1 |
1382 |
0.43 |
chr1_128758816_128759186 | 7.21 |
Gm29599 |
predicted gene 29599 |
8075 |
0.23 |
chr2_32625098_32626151 | 7.18 |
Ak1 |
adenylate kinase 1 |
186 |
0.86 |
chr2_90917239_90918445 | 7.17 |
Ptpmt1 |
protein tyrosine phosphatase, mitochondrial 1 |
15 |
0.71 |
chr5_33689860_33690118 | 7.15 |
Gm42965 |
predicted gene 42965 |
7015 |
0.11 |
chr1_72823832_72824380 | 7.14 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
397 |
0.88 |
chr13_52284136_52284287 | 7.14 |
Gm48199 |
predicted gene, 48199 |
103800 |
0.07 |
chr9_83145596_83146040 | 7.14 |
Gm29054 |
predicted gene 29054 |
97 |
0.9 |
chr1_166137971_166138483 | 7.12 |
Gpa33 |
glycoprotein A33 (transmembrane) |
7760 |
0.17 |
chr1_118589777_118590081 | 7.12 |
Clasp1 |
CLIP associating protein 1 |
14798 |
0.17 |
chr8_93569469_93569647 | 7.11 |
Gm45708 |
predicted gene 45708 |
5885 |
0.21 |
chr4_95156807_95157278 | 7.09 |
Gm28096 |
predicted gene 28096 |
5302 |
0.19 |
chr13_93637737_93637888 | 7.06 |
Bhmt |
betaine-homocysteine methyltransferase |
149 |
0.95 |
chr3_115708930_115709463 | 7.03 |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
5876 |
0.22 |
chr4_102383217_102383404 | 7.00 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
38208 |
0.22 |
chr8_120500387_120500853 | 6.99 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
12173 |
0.13 |
chr6_141434772_141434923 | 6.99 |
Gm43958 |
predicted gene, 43958 |
7513 |
0.27 |
chr8_83669020_83669289 | 6.98 |
Ptger1 |
prostaglandin E receptor 1 (subtype EP1) |
2012 |
0.18 |
chr14_54983182_54983333 | 6.95 |
Gm31251 |
predicted gene, 31251 |
3864 |
0.07 |
chr10_78574631_78574817 | 6.93 |
Ilvbl |
ilvB (bacterial acetolactate synthase)-like |
137 |
0.9 |
chr8_4192812_4193553 | 6.92 |
Evi5l |
ecotropic viral integration site 5 like |
1890 |
0.19 |
chr12_8443900_8444051 | 6.89 |
Gm48076 |
predicted gene, 48076 |
10943 |
0.16 |
chr1_69105762_69106339 | 6.87 |
Gm16076 |
predicted gene 16076 |
690 |
0.64 |
chr5_142821314_142822211 | 6.86 |
Tnrc18 |
trinucleotide repeat containing 18 |
4100 |
0.2 |
chr17_56470586_56470893 | 6.84 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
3888 |
0.18 |
chr13_46903132_46903283 | 6.83 |
Gm22960 |
predicted gene, 22960 |
618 |
0.65 |
chr8_82968493_82968673 | 6.83 |
Gm18212 |
predicted gene, 18212 |
16071 |
0.24 |
chr10_13982761_13983386 | 6.83 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
16049 |
0.19 |
chr17_27679167_27679824 | 6.82 |
Pacsin1 |
protein kinase C and casein kinase substrate in neurons 1 |
5686 |
0.12 |
chr3_96575222_96575957 | 6.82 |
Gm16253 |
predicted gene 16253 |
1395 |
0.19 |
chr17_56809917_56810952 | 6.82 |
Rfx2 |
regulatory factor X, 2 (influences HLA class II expression) |
20505 |
0.11 |
chr7_44310178_44311500 | 6.81 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
586 |
0.43 |
chr19_36553934_36555231 | 6.76 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr11_64309875_64310186 | 6.75 |
Hs3st3a1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
125302 |
0.05 |
chr12_86103895_86104165 | 6.74 |
Ift43 |
intraflagellar transport 43 |
11908 |
0.15 |
chr11_52098162_52099642 | 6.74 |
Ppp2ca |
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
221 |
0.52 |
chr2_92375145_92375948 | 6.73 |
Pex16 |
peroxisomal biogenesis factor 16 |
13 |
0.91 |
chr1_74103754_74104304 | 6.73 |
Tns1 |
tensin 1 |
5353 |
0.18 |
chr9_21762154_21762705 | 6.72 |
Spc24 |
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
2126 |
0.2 |
chr2_71517791_71517985 | 6.71 |
Metap1d |
methionyl aminopeptidase type 1D (mitochondrial) |
2476 |
0.2 |
chr18_10787613_10787791 | 6.71 |
Mir133a-1hg |
Mir133a-1, Mir1b and Mir1a-2 host gene |
1819 |
0.19 |
chr14_12388940_12389425 | 6.67 |
Cadps |
Ca2+-dependent secretion activator |
11903 |
0.13 |
chr14_66839148_66839299 | 6.67 |
Dpysl2 |
dihydropyrimidinase-like 2 |
29465 |
0.13 |
chr5_149513472_149514426 | 6.65 |
Gm2566 |
predicted gene 2566 |
10897 |
0.13 |
chr15_89497687_89498042 | 6.64 |
Gm41381 |
predicted gene, 41381 |
85 |
0.93 |
chr4_87211400_87211586 | 6.63 |
Slc24a2 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 |
16380 |
0.27 |
chr8_95703143_95704225 | 6.62 |
Ndrg4 |
N-myc downstream regulated gene 4 |
614 |
0.57 |
chr15_67898912_67899432 | 6.61 |
Gm49408 |
predicted gene, 49408 |
25344 |
0.23 |
chr11_75509773_75510993 | 6.61 |
Rilp |
Rab interacting lysosomal protein |
84 |
0.93 |
chr1_88254702_88255947 | 6.60 |
Mroh2a |
maestro heat-like repeat family member 2A |
2434 |
0.15 |
chr9_40420926_40421258 | 6.58 |
Gramd1b |
GRAM domain containing 1B |
19223 |
0.14 |
chr4_86183702_86183912 | 6.56 |
Adamtsl1 |
ADAMTS-like 1 |
15510 |
0.29 |
chr5_30920760_30922186 | 6.56 |
Khk |
ketohexokinase |
42 |
0.93 |
chr13_46909294_46909445 | 6.55 |
Gm22960 |
predicted gene, 22960 |
6780 |
0.14 |
chr7_16119631_16120684 | 6.54 |
Kptn |
kaptin |
62 |
0.96 |
chr1_131770683_131771116 | 6.54 |
Slc26a9 |
solute carrier family 26, member 9 |
20408 |
0.14 |
chr13_24620418_24620826 | 6.53 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
5995 |
0.21 |
chr12_86652768_86653097 | 6.52 |
Gm22004 |
predicted gene, 22004 |
2193 |
0.23 |
chr1_170651390_170651677 | 6.52 |
Olfml2b |
olfactomedin-like 2B |
7001 |
0.19 |
chr8_45607073_45607301 | 6.51 |
Gm16351 |
predicted gene 16351 |
2047 |
0.3 |
chr9_25695060_25695323 | 6.49 |
Gm48330 |
predicted gene, 48330 |
9828 |
0.24 |
chr5_111761615_111761950 | 6.49 |
E130006D01Rik |
RIKEN cDNA E130006D01 gene |
57 |
0.97 |
chr9_108936375_108937271 | 6.48 |
Uqcrc1 |
ubiquinol-cytochrome c reductase core protein 1 |
69 |
0.94 |
chr7_113250698_113250986 | 6.48 |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
11088 |
0.2 |
chr16_97534839_97535682 | 6.48 |
Mx2 |
MX dynamin-like GTPase 2 |
48 |
0.97 |
chr3_53707246_53707397 | 6.47 |
Gm6204 |
predicted gene 6204 |
14443 |
0.13 |
chr10_80302176_80302965 | 6.44 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
750 |
0.36 |
chr11_101732407_101733143 | 6.43 |
Dhx8 |
DEAH (Asp-Glu-Ala-His) box polypeptide 8 |
144 |
0.94 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 17.6 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
3.5 | 24.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
3.1 | 6.3 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
2.8 | 8.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.7 | 8.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
2.7 | 8.0 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.6 | 10.5 | GO:0030035 | microspike assembly(GO:0030035) |
2.6 | 7.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
2.6 | 7.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.6 | 7.7 | GO:0021564 | vagus nerve development(GO:0021564) |
2.3 | 7.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.3 | 7.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
2.3 | 2.3 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
2.2 | 8.9 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
2.2 | 6.7 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
2.1 | 6.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
2.1 | 10.5 | GO:0033762 | response to glucagon(GO:0033762) |
2.1 | 6.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.1 | 10.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.0 | 14.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
2.0 | 8.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.0 | 5.9 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.9 | 7.7 | GO:0030091 | protein repair(GO:0030091) |
1.9 | 13.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.9 | 5.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.9 | 5.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.9 | 5.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.8 | 1.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.8 | 17.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.8 | 12.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.8 | 5.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.8 | 5.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.8 | 3.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.7 | 3.4 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.7 | 6.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.7 | 8.5 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.7 | 6.7 | GO:0046959 | habituation(GO:0046959) |
1.7 | 6.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.7 | 6.6 | GO:0007412 | axon target recognition(GO:0007412) |
1.6 | 4.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.6 | 8.2 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.6 | 14.6 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.5 | 4.6 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
1.5 | 1.5 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
1.5 | 3.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.5 | 3.0 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.5 | 4.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.4 | 5.8 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.4 | 5.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.4 | 2.9 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.4 | 8.6 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.4 | 4.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.4 | 7.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.4 | 5.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.4 | 5.7 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
1.4 | 4.2 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.4 | 6.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.4 | 4.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.4 | 4.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.4 | 5.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.4 | 5.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.4 | 1.4 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.4 | 5.4 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.4 | 5.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.3 | 6.7 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
1.3 | 9.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.3 | 2.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.3 | 4.0 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.3 | 9.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.3 | 1.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.3 | 6.5 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
1.3 | 1.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.3 | 3.8 | GO:0036257 | multivesicular body organization(GO:0036257) |
1.3 | 10.2 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
1.3 | 7.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.3 | 5.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.3 | 1.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.3 | 8.8 | GO:0006108 | malate metabolic process(GO:0006108) |
1.2 | 3.7 | GO:0033058 | directional locomotion(GO:0033058) |
1.2 | 2.5 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.2 | 3.7 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.2 | 1.2 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
1.2 | 6.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.2 | 5.9 | GO:0035989 | tendon development(GO:0035989) |
1.2 | 1.2 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.2 | 1.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.2 | 2.3 | GO:0030421 | defecation(GO:0030421) |
1.2 | 1.2 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.2 | 3.5 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.2 | 2.3 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
1.1 | 8.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.1 | 1.1 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
1.1 | 2.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.1 | 11.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.1 | 3.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.1 | 3.3 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
1.1 | 2.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.1 | 3.3 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.1 | 1.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.1 | 3.3 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.1 | 5.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
1.1 | 6.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.1 | 3.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.1 | 3.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.1 | 3.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.1 | 3.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.1 | 3.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.1 | 3.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.1 | 11.7 | GO:0060736 | prostate gland growth(GO:0060736) |
1.1 | 1.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
1.1 | 8.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.1 | 1.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
1.1 | 4.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.0 | 2.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.0 | 3.1 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
1.0 | 4.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
1.0 | 2.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
1.0 | 4.1 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.0 | 3.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.0 | 1.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.0 | 3.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.0 | 6.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.0 | 3.0 | GO:0051182 | coenzyme transport(GO:0051182) |
1.0 | 3.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.0 | 3.0 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.0 | 8.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.0 | 2.9 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.0 | 4.8 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.0 | 1.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
1.0 | 4.8 | GO:0014028 | notochord formation(GO:0014028) |
1.0 | 1.9 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
1.0 | 2.9 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.9 | 2.8 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.9 | 8.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.9 | 2.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.9 | 11.1 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.9 | 1.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.9 | 0.9 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.9 | 1.8 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.9 | 6.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.9 | 1.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.9 | 3.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.9 | 2.6 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.9 | 4.3 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.9 | 1.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.9 | 10.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.9 | 2.6 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.8 | 2.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.8 | 4.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.8 | 5.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.8 | 3.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.8 | 2.5 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.8 | 3.3 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.8 | 0.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 3.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.8 | 2.4 | GO:0051665 | membrane raft localization(GO:0051665) |
0.8 | 0.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.8 | 3.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.8 | 6.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.8 | 3.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.8 | 2.4 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.8 | 1.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.8 | 7.2 | GO:0060013 | righting reflex(GO:0060013) |
0.8 | 11.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.8 | 1.6 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.8 | 2.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.8 | 2.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.8 | 3.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.8 | 2.3 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.8 | 2.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.8 | 3.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.8 | 4.7 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.8 | 2.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.8 | 3.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.8 | 1.5 | GO:1903416 | response to glycoside(GO:1903416) |
0.8 | 3.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.8 | 1.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.8 | 2.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.8 | 0.8 | GO:0071435 | potassium ion export(GO:0071435) |
0.8 | 4.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.8 | 2.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.8 | 2.3 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.7 | 1.5 | GO:0061525 | hindgut development(GO:0061525) |
0.7 | 3.0 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.7 | 1.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.7 | 6.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.7 | 1.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.7 | 1.5 | GO:0008355 | olfactory learning(GO:0008355) |
0.7 | 2.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.7 | 1.5 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.7 | 1.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.7 | 4.4 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.7 | 1.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.7 | 2.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.7 | 2.2 | GO:0019230 | proprioception(GO:0019230) |
0.7 | 2.9 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.7 | 5.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.7 | 0.7 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.7 | 0.7 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.7 | 2.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.7 | 1.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.7 | 0.7 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.7 | 6.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.7 | 2.8 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 1.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.7 | 2.8 | GO:0051195 | negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.7 | 4.9 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.7 | 2.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.7 | 0.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.7 | 2.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 | 12.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.7 | 2.0 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.7 | 2.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.7 | 0.7 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.7 | 1.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.7 | 2.0 | GO:1904684 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.7 | 5.3 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.7 | 1.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.7 | 4.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.7 | 0.7 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.7 | 3.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.7 | 0.7 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.7 | 0.7 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.6 | 3.9 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.6 | 5.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 0.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.6 | 11.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.6 | 1.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.6 | 2.6 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.6 | 3.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 1.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.6 | 2.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.6 | 2.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.6 | 1.3 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.6 | 0.6 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.6 | 1.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.6 | 3.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.6 | 1.9 | GO:0001927 | exocyst assembly(GO:0001927) |
0.6 | 3.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.6 | 1.3 | GO:0003207 | cardiac chamber formation(GO:0003207) |
0.6 | 3.8 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.6 | 0.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.6 | 1.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.6 | 2.5 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.6 | 1.9 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.6 | 0.6 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.6 | 1.8 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.6 | 12.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 3.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 1.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.6 | 1.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.6 | 1.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.6 | 0.6 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.6 | 4.2 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.6 | 3.6 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.6 | 1.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 3.6 | GO:0060004 | reflex(GO:0060004) |
0.6 | 3.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.6 | 1.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.6 | 1.8 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.6 | 0.6 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.6 | 9.0 | GO:0060074 | synapse maturation(GO:0060074) |
0.6 | 1.8 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.6 | 4.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.6 | 2.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.6 | 1.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.6 | 1.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.6 | 0.6 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.6 | 1.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.6 | 4.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.6 | 1.8 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.6 | 1.8 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.6 | 2.3 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.6 | 0.6 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.6 | 1.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.6 | 4.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.6 | 3.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.6 | 1.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.6 | 0.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.6 | 1.2 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.6 | 1.1 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.6 | 4.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.6 | 2.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.6 | 1.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.6 | 0.6 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.6 | 1.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 2.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.6 | 0.6 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.6 | 1.1 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.6 | 1.7 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.6 | 0.6 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.6 | 6.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 2.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.6 | 1.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.6 | 1.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.6 | 1.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.6 | 0.6 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.6 | 2.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 2.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.5 | 3.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.5 | 2.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.5 | 1.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 1.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.5 | 6.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.5 | 1.1 | GO:0015755 | fructose transport(GO:0015755) |
0.5 | 1.1 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.5 | 17.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.5 | 3.8 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.5 | 0.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.5 | 8.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.5 | 1.6 | GO:0040031 | snRNA modification(GO:0040031) |
0.5 | 2.7 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.5 | 1.6 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 1.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.5 | 1.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.5 | 8.5 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.5 | 4.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.5 | 5.3 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.5 | 1.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 0.5 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.5 | 1.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 7.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 3.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.5 | 7.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.5 | 5.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.5 | 2.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 1.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.5 | 3.6 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.5 | 2.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.5 | 4.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.5 | 2.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.5 | 2.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.5 | 2.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.5 | 2.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.5 | 2.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.5 | 1.0 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.5 | 3.0 | GO:0006983 | ER overload response(GO:0006983) |
0.5 | 0.5 | GO:0006971 | hypotonic response(GO:0006971) |
0.5 | 1.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 1.5 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.5 | 3.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.5 | 1.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 2.0 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.5 | 1.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.5 | 0.5 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.5 | 0.5 | GO:0015819 | lysine transport(GO:0015819) |
0.5 | 6.4 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.5 | 1.0 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.5 | 1.5 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.5 | 0.5 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.5 | 0.5 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.5 | 1.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.5 | 0.5 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.5 | 0.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.5 | 4.4 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.5 | 0.5 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.5 | 1.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 1.0 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.5 | 1.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.5 | 1.0 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.5 | 0.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.5 | 3.9 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.5 | 1.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 1.4 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.5 | 0.9 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.5 | 7.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 0.9 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.5 | 1.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.5 | 0.9 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.5 | 0.9 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.5 | 2.3 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.5 | 2.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 0.5 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.5 | 1.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.5 | 0.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.5 | 0.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.5 | 4.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.5 | 2.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.5 | 1.4 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.5 | 0.9 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.5 | 0.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.5 | 0.5 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.5 | 0.9 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.5 | 1.8 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.5 | 0.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 0.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.5 | 0.9 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.5 | 2.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.5 | 21.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 0.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.5 | 2.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.4 | 0.4 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.4 | 0.9 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.4 | 0.4 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.4 | 1.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 1.8 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.4 | 1.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 1.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 0.9 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.4 | 0.9 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 0.4 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 0.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 3.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 6.5 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.4 | 16.9 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.4 | 0.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 0.4 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.4 | 14.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 2.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 2.6 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.4 | 1.3 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 2.1 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.4 | 2.1 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.4 | 1.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 1.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.4 | 2.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 5.4 | GO:0014850 | response to muscle activity(GO:0014850) |
0.4 | 0.8 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.4 | 0.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 7.4 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.4 | 1.2 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.4 | 1.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.4 | 1.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 0.4 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.4 | 1.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 1.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.4 | 1.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.4 | 5.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 2.4 | GO:0007416 | synapse assembly(GO:0007416) |
0.4 | 1.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.4 | 0.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 5.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 0.8 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.4 | 0.4 | GO:0060594 | mammary gland specification(GO:0060594) |
0.4 | 0.8 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
0.4 | 10.7 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.4 | 1.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.4 | 2.8 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.4 | 1.2 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.4 | 1.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 0.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 3.9 | GO:0015858 | nucleoside transport(GO:0015858) |
0.4 | 3.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 0.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 2.0 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 0.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.4 | 0.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 0.8 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 2.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 0.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 3.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.4 | 1.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.4 | 1.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.4 | 0.8 | GO:0014029 | neural crest formation(GO:0014029) |
0.4 | 1.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 0.8 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.4 | 1.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.4 | 1.5 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.4 | 0.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 1.5 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.4 | 0.8 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 1.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.4 | 0.4 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.4 | 1.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 0.4 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.4 | 0.7 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.4 | 0.7 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.4 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.4 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.4 | 1.5 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.4 | 0.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 2.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.4 | 0.4 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.4 | 0.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 3.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 0.4 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.4 | 1.8 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.4 | 1.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.4 | 2.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 0.7 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.4 | 0.7 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.4 | 1.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.4 | 2.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.4 | 0.7 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.3 | 0.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 3.1 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) dendritic spine organization(GO:0097061) |
0.3 | 1.7 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.3 | 2.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 2.8 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.3 | 1.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 5.9 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.3 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 3.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 1.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 1.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 0.3 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 1.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.3 | 1.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 0.3 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.3 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 1.0 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 1.0 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.3 | 2.0 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.3 | 1.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.3 | 1.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 0.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.3 | 1.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 1.0 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.3 | 1.3 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.3 | 0.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.3 | 2.7 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.3 | 0.3 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.3 | 10.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.3 | 1.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 4.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 2.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 1.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.3 | 2.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.3 | 0.3 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.3 | 1.6 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.3 | 2.6 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.3 | 0.6 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.3 | 0.3 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.3 | 1.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 0.6 | GO:1901213 | regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901213) |
0.3 | 1.6 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.3 | 1.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 0.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 0.6 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 3.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 0.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 2.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 0.6 | GO:0007494 | midgut development(GO:0007494) |
0.3 | 0.3 | GO:0072239 | metanephric glomerulus vasculature development(GO:0072239) |
0.3 | 1.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 3.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.3 | 0.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.3 | 1.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.3 | 0.9 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.3 | 1.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.3 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.9 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 0.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 0.9 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.3 | 0.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 1.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 1.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 1.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 0.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 3.3 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.3 | 2.4 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.3 | 6.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 0.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 3.3 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.3 | 0.6 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.3 | 0.9 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 0.3 | GO:0035483 | gastric emptying(GO:0035483) |
0.3 | 2.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.3 | 0.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.9 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.3 | 2.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.3 | 0.9 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.3 | 1.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 0.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 0.9 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.3 | 1.8 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 0.6 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.3 | 0.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 1.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 4.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 0.9 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.3 | 0.6 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 0.9 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.3 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 0.3 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.3 | 2.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.3 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 1.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 1.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.3 | 0.9 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.3 | 1.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 0.3 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.3 | 1.4 | GO:0043586 | tongue development(GO:0043586) |
0.3 | 0.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 11.2 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.3 | 0.8 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.3 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.3 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.3 | 1.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.3 | 1.7 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.3 | 2.5 | GO:0080111 | DNA demethylation(GO:0080111) |
0.3 | 1.1 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.3 | 1.1 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 1.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 0.5 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.3 | 3.8 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.3 | 0.8 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 0.5 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.3 | 0.3 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.3 | 1.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.3 | 1.1 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.3 | 3.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.3 | 2.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.3 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 3.5 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.3 | 0.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.3 | 0.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.3 | 3.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 0.3 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.3 | 0.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.3 | 0.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 8.4 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.3 | 0.3 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.3 | 2.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 1.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 3.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.3 | 2.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 0.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 0.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 2.6 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 0.8 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.3 | 3.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.3 | 0.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 1.5 | GO:0021988 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
0.3 | 0.3 | GO:0090102 | cochlea development(GO:0090102) |
0.3 | 3.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.3 | 0.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 3.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.3 | 0.5 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.3 | 0.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.3 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 1.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 1.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 1.7 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.2 | 0.7 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.2 | 1.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 0.7 | GO:0071625 | vocalization behavior(GO:0071625) |
0.2 | 1.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.2 | 0.7 | GO:0097178 | ruffle assembly(GO:0097178) |
0.2 | 1.0 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.2 | 1.0 | GO:1902031 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.2 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) |
0.2 | 0.7 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.2 | 0.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.2 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 2.9 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.2 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 1.9 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.2 | 0.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.7 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 1.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 0.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 1.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 1.9 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 0.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.2 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.2 | 0.2 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.2 | 2.5 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 6.4 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.2 | GO:0021885 | forebrain cell migration(GO:0021885) |
0.2 | 0.7 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 1.4 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.2 | 1.8 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.4 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 0.7 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.2 | 2.7 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.2 | 1.1 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.9 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 2.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 3.7 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.2 | 1.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 0.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 1.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.2 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 5.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 1.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.4 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.2 | 0.4 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 0.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.4 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 3.0 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.2 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.2 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 1.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.8 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 13.2 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.2 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 1.0 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.2 | 1.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 3.9 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.2 | 0.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 1.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.6 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 0.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.6 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 1.8 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.2 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 0.4 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.2 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 1.0 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.2 | 1.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 1.0 | GO:0060433 | bronchus development(GO:0060433) lobar bronchus epithelium development(GO:0060481) |
0.2 | 0.6 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.8 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 0.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.2 | 1.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 3.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 0.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.6 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 2.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.4 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 3.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.2 | 0.4 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.2 | 0.2 | GO:1902990 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.2 | 0.6 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 1.1 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.8 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 0.2 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.2 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 2.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.6 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.2 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 2.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 1.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.4 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 0.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.4 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 0.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.2 | 0.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.2 | 0.2 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 0.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 0.2 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 2.1 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.2 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.2 | 0.4 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.2 | 0.3 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 1.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 0.3 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.2 | 1.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.3 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.3 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.3 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.2 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 2.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.8 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.2 | 0.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.2 | GO:0031063 | regulation of histone deacetylation(GO:0031063) regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.5 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.2 | 0.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 0.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.2 | 0.3 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 0.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 0.6 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.2 | 0.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 3.4 | GO:0045665 | negative regulation of neuron differentiation(GO:0045665) |
0.2 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.2 | 4.3 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.2 | 0.5 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.2 | 1.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.2 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 0.2 | GO:0060438 | trachea development(GO:0060438) |
0.2 | 0.9 | GO:0035640 | exploration behavior(GO:0035640) |
0.2 | 4.4 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.2 | 0.9 | GO:0060384 | innervation(GO:0060384) |
0.1 | 1.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 1.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.6 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.7 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 1.5 | GO:0001936 | regulation of endothelial cell proliferation(GO:0001936) |
0.1 | 1.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 1.2 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.1 | 0.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 1.2 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.3 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.1 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
0.1 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.1 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
0.1 | 0.7 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 | 1.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.1 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.3 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 0.3 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.3 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.1 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.8 | GO:0098868 | bone growth(GO:0098868) |
0.1 | 0.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 3.0 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 0.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.7 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.3 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.1 | 0.3 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.8 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.5 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 0.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 1.0 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 1.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 2.3 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.1 | 0.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 1.3 | GO:0007595 | lactation(GO:0007595) |
0.1 | 1.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 1.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.9 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.1 | 0.9 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.1 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 2.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.5 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 1.0 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.1 | 0.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.1 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.8 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:0033080 | immature T cell proliferation(GO:0033079) immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) |
0.1 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.8 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.2 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 1.7 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 2.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.5 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.3 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.7 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.6 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.2 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.6 | GO:0090109 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
0.1 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.4 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 1.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.4 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.4 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.1 | 0.3 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 0.7 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.1 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.2 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.1 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.4 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.5 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.5 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.6 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.3 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.4 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.5 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.1 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.6 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.3 | GO:0002786 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.1 | 0.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 0.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 1.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.4 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.7 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.7 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.1 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 1.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 0.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.2 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.1 | 0.2 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.1 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.1 | 4.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.1 | 1.2 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.2 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.1 | 0.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.4 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.1 | 0.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 1.6 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.1 | 0.5 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 2.7 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.1 | 0.8 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.5 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 0.7 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.1 | 0.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 1.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.4 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 1.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.1 | GO:0032819 | positive regulation of interleukin-17 production(GO:0032740) regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.2 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.1 | 0.1 | GO:0003157 | endocardium development(GO:0003157) |
0.1 | 0.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.4 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 1.3 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.1 | GO:0072074 | kidney mesenchyme development(GO:0072074) |
0.1 | 0.1 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.8 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.0 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.0 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 2.0 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.1 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.0 | 0.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.5 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.0 | 1.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.0 | 0.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.0 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.4 | GO:0001756 | somitogenesis(GO:0001756) |
0.0 | 0.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 1.3 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.2 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.7 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.1 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.9 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.0 | 0.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.0 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.0 | 0.1 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.0 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.1 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.0 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.0 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.0 | 0.0 | GO:0061387 | regulation of extent of cell growth(GO:0061387) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.1 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.0 | 0.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.0 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.0 | 0.0 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) |
0.0 | 0.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.1 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.0 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.0 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.0 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.0 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
2.7 | 8.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
2.7 | 8.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
2.4 | 19.1 | GO:0001520 | outer dense fiber(GO:0001520) |
2.4 | 14.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
2.1 | 6.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
2.0 | 6.1 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.0 | 13.8 | GO:0045180 | basal cortex(GO:0045180) |
1.8 | 5.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.7 | 10.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.7 | 6.7 | GO:0097452 | GAIT complex(GO:0097452) |
1.6 | 8.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.6 | 4.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.5 | 11.6 | GO:0005861 | troponin complex(GO:0005861) |
1.4 | 1.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.4 | 11.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.4 | 5.5 | GO:1990696 | USH2 complex(GO:1990696) |
1.3 | 2.7 | GO:0097427 | microtubule bundle(GO:0097427) |
1.3 | 1.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.3 | 6.6 | GO:0070695 | FHF complex(GO:0070695) |
1.3 | 5.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.2 | 4.7 | GO:0071953 | elastic fiber(GO:0071953) |
1.2 | 2.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.2 | 16.2 | GO:0031430 | M band(GO:0031430) |
1.1 | 7.9 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.1 | 10.6 | GO:0001527 | microfibril(GO:0001527) |
1.0 | 4.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.0 | 3.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.9 | 2.7 | GO:0055087 | Ski complex(GO:0055087) |
0.9 | 3.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.9 | 3.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.9 | 16.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.9 | 2.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.9 | 2.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.9 | 2.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.8 | 0.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.8 | 3.1 | GO:0030478 | actin cap(GO:0030478) |
0.8 | 1.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.8 | 9.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.7 | 6.0 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.7 | 1.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.7 | 4.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.7 | 4.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.7 | 2.1 | GO:1990393 | 3M complex(GO:1990393) |
0.7 | 4.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 0.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.7 | 10.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.7 | 9.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.7 | 4.0 | GO:0097342 | ripoptosome(GO:0097342) |
0.6 | 3.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.6 | 3.9 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.6 | 17.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.6 | 8.9 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.6 | 2.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.6 | 3.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.6 | 5.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.6 | 6.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.6 | 5.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.6 | 2.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 3.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 2.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 4.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.6 | 2.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.6 | 6.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 2.3 | GO:0097433 | dense body(GO:0097433) |
0.6 | 6.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.5 | 2.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.5 | 1.6 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 3.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.5 | 1.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 5.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 1.6 | GO:0030689 | Noc complex(GO:0030689) |
0.5 | 6.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 5.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 4.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 1.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 1.5 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.5 | 3.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.5 | 21.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.5 | 3.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 4.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 2.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 8.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.5 | 1.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.5 | 1.5 | GO:0031417 | NatC complex(GO:0031417) |
0.5 | 1.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.5 | 18.8 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.5 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.5 | 1.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.5 | 2.8 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 8.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.5 | 1.4 | GO:0071203 | WASH complex(GO:0071203) |
0.4 | 2.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 1.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.4 | 8.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.4 | 2.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.4 | 58.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.4 | 7.0 | GO:0031672 | A band(GO:0031672) |
0.4 | 4.1 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 2.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 3.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 1.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.4 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.4 | 1.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 3.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 2.2 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 3.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 3.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 0.4 | GO:0044393 | microspike(GO:0044393) |
0.3 | 2.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 2.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 1.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 19.1 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 8.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 1.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.3 | GO:0043205 | fibril(GO:0043205) |
0.3 | 3.0 | GO:0031256 | leading edge membrane(GO:0031256) |
0.3 | 2.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 17.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 3.6 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 2.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.0 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 2.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 1.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 1.3 | GO:0032021 | NELF complex(GO:0032021) |
0.3 | 1.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 7.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 0.9 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 0.9 | GO:0030669 | clathrin coat of endocytic vesicle(GO:0030128) endocytic vesicle membrane(GO:0030666) clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.3 | 1.5 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 1.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 2.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 4.2 | GO:0001741 | XY body(GO:0001741) |
0.3 | 0.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 7.8 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 5.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 0.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 0.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 0.8 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 2.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 2.7 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 1.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 6.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 15.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 1.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 1.5 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 3.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.3 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 1.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 0.7 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 1.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 3.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.7 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 1.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 3.2 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 0.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 2.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 1.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.9 | GO:0098576 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.2 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 4.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 1.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 2.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 1.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 1.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 2.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 2.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 0.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 0.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 4.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 1.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 10.9 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.9 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 0.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 1.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.7 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 4.8 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 5.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 0.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.2 | 3.0 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 2.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 1.8 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 4.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 1.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 1.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 5.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 3.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 11.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 1.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 1.7 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 2.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 6.2 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 2.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 7.1 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 9.3 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 1.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.5 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 3.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 6.5 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 4.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 1.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 1.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 3.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 1.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 26.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 23.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 11.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 1.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 28.1 | GO:0045202 | synapse(GO:0045202) |
0.1 | 1.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 1.2 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 1.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 2.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.4 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 10.2 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.8 | GO:0032155 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.1 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.4 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.1 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 2.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 1.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.2 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.0 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
0.0 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 7.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 2.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 2.1 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 1.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.5 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.7 | GO:0051373 | FATZ binding(GO:0051373) |
2.7 | 8.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
2.5 | 7.6 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
2.5 | 7.5 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
2.1 | 4.3 | GO:0030172 | troponin C binding(GO:0030172) |
2.1 | 6.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.1 | 6.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
2.1 | 2.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.0 | 6.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.0 | 6.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.9 | 5.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.8 | 5.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.8 | 5.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.8 | 16.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.8 | 5.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.7 | 5.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.7 | 22.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.7 | 5.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.7 | 5.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.7 | 1.7 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
1.7 | 5.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.7 | 11.7 | GO:0031432 | titin binding(GO:0031432) |
1.7 | 8.3 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
1.6 | 6.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.6 | 6.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.6 | 4.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.5 | 22.9 | GO:0030955 | potassium ion binding(GO:0030955) |
1.5 | 6.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.5 | 9.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.4 | 5.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.4 | 1.4 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
1.4 | 6.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.4 | 5.4 | GO:0042731 | PH domain binding(GO:0042731) |
1.4 | 4.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.3 | 5.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.3 | 4.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.3 | 7.5 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.2 | 6.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.2 | 4.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.2 | 9.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.2 | 2.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.1 | 4.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.1 | 5.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.1 | 1.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.1 | 5.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.1 | 6.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.1 | 3.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.1 | 3.2 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.1 | 3.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.1 | 3.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.1 | 7.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.1 | 6.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.0 | 3.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.0 | 5.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.0 | 3.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.0 | 9.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.0 | 5.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.0 | 17.7 | GO:0005112 | Notch binding(GO:0005112) |
1.0 | 2.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.0 | 1.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.9 | 2.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.9 | 2.8 | GO:0030911 | TPR domain binding(GO:0030911) |
0.9 | 3.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.9 | 8.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.9 | 4.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.9 | 3.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.9 | 2.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.9 | 3.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.9 | 2.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.9 | 4.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.9 | 3.5 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.9 | 5.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.9 | 6.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.8 | 2.5 | GO:0055100 | adiponectin binding(GO:0055100) |
0.8 | 3.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.8 | 7.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.8 | 1.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.8 | 2.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.8 | 2.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.8 | 6.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.8 | 4.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.8 | 4.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.8 | 8.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.8 | 1.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.8 | 8.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.8 | 3.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.8 | 5.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.7 | 1.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.7 | 3.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 6.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.7 | 2.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.7 | 3.0 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.7 | 5.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.7 | 13.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.7 | 3.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 2.9 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.7 | 2.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.7 | 26.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.7 | 4.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.7 | 2.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.7 | 2.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.7 | 4.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.7 | 2.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 5.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.7 | 2.1 | GO:2001070 | starch binding(GO:2001070) |
0.7 | 4.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.7 | 2.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.7 | 3.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.7 | 1.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 6.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.7 | 9.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.7 | 2.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.6 | 1.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.6 | 9.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.6 | 3.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 2.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 2.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.6 | 7.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.6 | 0.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.6 | 4.4 | GO:0018651 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.6 | 5.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.6 | 1.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.6 | 5.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 2.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.6 | 2.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.6 | 2.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.6 | 1.2 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.6 | 1.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.6 | 1.8 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.6 | 4.1 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 1.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.6 | 5.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.6 | 3.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.6 | 6.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 3.5 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.6 | 1.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 4.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 2.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.6 | 2.8 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.6 | 1.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.6 | 1.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.6 | 2.2 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 2.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.5 | 1.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.5 | 2.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 2.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 5.9 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.5 | 10.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 1.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 2.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 1.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.5 | 11.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.5 | 4.6 | GO:0052686 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.5 | 2.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 5.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 1.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.5 | 1.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 2.5 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.5 | 18.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.5 | 2.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.5 | 1.5 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.5 | 5.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.5 | 0.5 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.5 | 0.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.5 | 6.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.5 | 1.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.5 | 1.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.5 | 13.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 1.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.5 | 5.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 1.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.5 | 1.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 4.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 31.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.5 | 4.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 3.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.5 | 1.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 4.6 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.5 | 8.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 3.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 3.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 1.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 3.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 1.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 3.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 2.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 1.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.4 | 1.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 1.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 4.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.4 | 1.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 2.5 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 1.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.4 | 2.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 2.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 6.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.4 | 1.6 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 1.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 0.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.4 | 11.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 0.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.4 | 1.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 2.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 1.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 4.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 1.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 1.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 3.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.9 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 0.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 0.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 2.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 8.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 1.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.4 | 1.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 3.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.4 | 0.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 3.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 7.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.4 | 4.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 1.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.4 | 1.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 0.4 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.4 | 3.5 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 3.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.4 | 2.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 3.9 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.3 | 0.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 1.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 12.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 1.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 15.4 | GO:0017022 | myosin binding(GO:0017022) |
0.3 | 2.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 7.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 2.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.3 | 1.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 6.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 3.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 1.6 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 0.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 2.9 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 3.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 0.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 1.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 3.5 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.3 | 2.2 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.3 | 2.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.3 | 0.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 1.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 5.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 3.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 1.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 3.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 0.9 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 3.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 1.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 0.6 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 1.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 1.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 3.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 2.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 0.9 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 4.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 0.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 2.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 0.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 0.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 10.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.3 | 3.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 7.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 0.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 2.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 0.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 4.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 0.8 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 0.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.3 | 26.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 1.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 1.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.3 | 2.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 1.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.3 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 1.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 4.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 0.8 | GO:0097617 | annealing activity(GO:0097617) |
0.3 | 3.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 0.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 1.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 0.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 2.7 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 2.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 4.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 1.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 1.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.2 | 2.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 1.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 8.7 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.2 | 3.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 2.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 4.5 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 1.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 11.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 0.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 2.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 2.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 1.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.4 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 1.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.1 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 0.2 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.2 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 2.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 3.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 0.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 3.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 5.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.2 | 0.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 3.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 51.2 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 0.8 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 2.2 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 1.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 3.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.6 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 1.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 0.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 2.5 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.2 | 1.4 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.2 | 2.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 1.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 2.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 2.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 1.4 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 1.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 1.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 3.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 10.5 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.2 | 0.3 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 9.1 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 10.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 4.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 1.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 2.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.2 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.2 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 1.5 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.8 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 2.4 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 5.2 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.7 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 1.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.8 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 2.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 18.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 1.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 1.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.8 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity(GO:0004532) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.1 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 2.7 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 1.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 8.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 1.3 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.6 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:0043909 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 1.5 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0018542 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.2 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 0.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 1.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 2.8 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.3 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 2.2 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 1.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.4 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 1.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.4 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 14.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.0 | 3.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.0 | 2.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.8 | 1.6 | ST ADRENERGIC | Adrenergic Pathway |
0.8 | 22.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.8 | 18.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.7 | 4.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.6 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 25.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 22.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 3.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 1.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 5.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 2.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 1.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 2.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 19.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 4.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.5 | 14.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 10.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.5 | 2.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 21.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.4 | 1.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 7.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 13.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.4 | 0.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 7.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 7.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 0.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 5.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.4 | 2.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 6.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 0.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 1.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 5.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 7.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 4.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 5.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 1.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 4.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 3.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 1.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 2.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 1.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 8.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 3.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 3.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 3.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 4.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 2.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 3.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 3.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 0.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 4.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 5.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 4.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 1.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 11.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 4.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 1.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 3.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 2.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 3.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 2.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 3.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 19.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 18.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 3.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 4.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 1.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 2.0 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 3.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 23.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
1.2 | 1.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.1 | 2.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.1 | 8.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.1 | 11.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.0 | 9.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.0 | 8.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.9 | 12.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.8 | 2.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.8 | 8.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.7 | 1.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.7 | 1.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.7 | 31.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.7 | 15.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 41.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.7 | 17.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.7 | 5.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.7 | 11.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.6 | 15.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.6 | 1.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.6 | 13.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.6 | 8.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.6 | 5.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 0.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.6 | 10.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.6 | 11.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.6 | 5.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 6.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 11.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.5 | 27.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 20.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 3.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 11.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 5.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 0.5 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.5 | 5.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.5 | 6.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.5 | 4.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 6.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 9.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 1.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.5 | 3.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.5 | 5.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 7.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 5.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 8.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.4 | 8.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 5.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 1.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 4.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.4 | 8.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 1.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 7.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 1.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 3.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 1.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 2.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 11.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 0.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 0.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 1.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 6.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 5.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 3.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 2.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 3.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.3 | 1.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 2.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 8.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 2.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 4.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 4.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 2.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 1.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 9.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 2.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 2.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 1.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 1.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 2.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 2.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 1.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 0.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 8.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 2.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 9.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 4.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 1.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 1.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 1.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 1.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 3.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 1.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.6 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 2.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 2.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 2.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 2.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 1.5 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 1.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.2 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.0 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |